Intracranial hemorrhage in cancer patients treated with anticoagulation

Thrombosis Research

Volumn 140, Issue , 2016, Pages S60-S65

  Weinstock, Matthew J ^a   Uhlmann, Erik J ^b   Zwicker, Jeffrey I ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anticoagulation; Brain metastases; Intracranial hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; CORTICOSTEROID; HEPARIN; IDARUCIZUMAB; RIVAROXABAN; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN TUMOR; CANCER PATIENT; DEEP VEIN THROMBOSIS; HUMAN; INCIDENCE; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD CLOTTING; BRAIN; BRAIN NEOPLASMS; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; INTRACRANIAL HEMORRHAGES; VASCULARIZATION;

ANTICOAGULANTS; BLOOD COAGULATION; BRAIN; BRAIN NEOPLASMS; HUMANS; INTRACRANIAL HEMORRHAGES; VENOUS THROMBOEMBOLISM;

EID: 84962877311     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(16)30100-1     Document Type: Article

References (48)

1. J.A. Heit, W.M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, D.N. Mohr, and et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study Arch Intern Med. 162 2002 1245 1248
2. J.F. Timp, S.K. Braekkan, H.H. Versteeg, and S.C. Cannegieter Epidemiology of cancer-associated venous thrombosis Blood. 122 2013 1712 1723
3. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost. 5 2007 632 634
4. M. Carrier, G. Le Gal, P.S. Wells, and M.A. Rodger Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism Ann Intern Med. 152 2010 578 589
5. E.M. Hylek, and D.E. Singer Risk factors for intracranial hemorrhage in outpatients taking warfarin Ann Intern Med. 120 1994 897 902
6. L. Sjoblom, H.G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, and et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study Stroke. 32 2001 2567 2574
7. Common Terminology Criteria for Adverse Events (CTCAE) v4.0 by U.S. Department of Health and Human Services http://www.hrc.govt.nz/sites/default/files/CTCAE%20manual%20-%20DMCC.pdf 2010
8. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost. 3 2005 692 694
9. J.P. Broderick, T.G. Brott, J.E. Duldner, T. Tomsick, and G. Huster Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality Stroke 24 1993 987 993
10. C.W. Wang, Y.J. Liu, Y.H. Lee, D.Y. Hueng, H.C. Fan, F.C. Yang, and et al. Hematoma shape, hematoma size, Glasgow coma scale score and ICH score: which predicts the 30-day mortality better for intracerebral hematoma? PLoS One. 9 2014 e102326
11. D.S. Russell Spontaneous intracranial haemorrhage Proceedings of the Royal Society of Medicine. 47 1954 689 693
12. M. Scott Spontaneous intracerebral hematoma caused by cerebral neoplasms. Report of eight verified cases J Neurosurg 42 1975 338 342
13. S. Wakai, K. Yamakawa, S. Manaka, and K. Takakura Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance Neurosurgery. 10 1982 437 444
14. J. Donato, F. Campigotto, E.J. Uhlmann, E. Coletti, and D. Neuberg Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study 126 2015 494 499
15. J.T. Jo, D. Schiff, and J.R. Perry Thrombosis in brain tumors Semin Thromb Hemost. 40 2014 325 331
16. S. Yust-Katz, J.J. Mandel, J. Wu, Y. Yuan, C. Webre, T.A. Pawar, and et al. Venous thromboembolism (VTE) and glioblastoma J Neurooncol. 124 2015 87 94
17. A.K. Choucair, P. Silver, and V.A. Levin Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism J Neurosurg. 66 1987 357 358
18. D. Schiff, and L.M. DeAngelis Therapy of venous thromboembolism in patients with brain metastases Cancer. 73 1994 493 498
19. G. Alvarado, R. Noor, R. Bassett, N.E. Papadopoulos, K.B. Kim, W.J. Hwu, and et al. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases Melanoma research. 22 2012 310 315
20. C.J. van Asch, M.J. Luitse, G.J. Rinkel, I. van der Tweel, A. Algra, and C.J. Klijn Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis The Lancet Neurology. 9 2010 167 176
21. R. Senn, M.S. Elkind, J. Montaner, M. Christ-Crain, and M. Katan Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage Cerebrovascular diseases (Basel, Switzerland) 38 2014 395 409
22. R.F. Keep, Y. Hua, and G. Xi Intracerebral haemorrhage: mechanisms of injury and therapeutic targets The Lancet Neurology. 11 2012 720 731
23. A.I. Qureshi, A.D. Mendelow, and D.F. Hanley Intracerebral haemorrhage Lancet. 373 2009 1632 1644
24. T. Olsson, N. Marklund, Y. Gustafson, and B. Nasman Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke Stroke. 23 1992 1573 1576
25. G. Xi, G. Reiser, and R.F. Keep The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? Journal of neurochemistry. 84 2003 3 9
26. F.P. Huang, G. Xi, R.F. Keep, Y. Hua, A. Nemoianu, and J.T. Hoff Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products J Neurosurg. 96 2002 287 293
27. R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability Circ Res. 94 2004 664 670
28. S.Y. Cheng, M. Nagane, H.S. Huang, and W.K. Cavenee Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 Proc Natl Acad Sci U S A. 94 1997 12081 12087
29. Y. Jin Kim, C. Hyun Kim, J. Hwan Cheong, and Kim J. Min Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas Tumori. 97 2011 639 646
30. J. Rubenstein, N. Fischbein, K. Aldape, E. Burton, and M. Shuman Hemorrhage and VEGF expression in a case of primary CNS lymphoma J Neurooncol. 58 2002 53 56
31. N. Kimura, M. Ishibashi, T. Masuda, M. Morishige, T. Abe, M. Fujiki, and et al. Primary central nervous system lymphoma with cortical laminar hemorrhage Journal of the neurological sciences. 287 2009 281 284
32. S. Bitoh, H. Hasegawa, H. Ohtsuki, J. Obashi, M. Fujiwara, and M. Sakurai Cerebral neoplasms initially presenting with massive intracerebral hemorrhage Surgical neurology. 22 1984 57 62
33. A.G. Marneros Tumor angiogenesis in melanoma Hematology/oncology clinics of North America. 23 2009 431 446 vii-viii
34. A.J. Pantuck, G. Zeng, A.S. Belldegrun, and R.A. Figlin Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway Clin Cancer Res. 9 2003 4641 4652
35. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science. 295 2002 2387 2392
36. P. Gaetani, R. Rodriguez y Baena, F. Tartara, A.L. Messina, F. Tancioni, R. Schiavo, and et al. Metalloproteases and intracranial vascular lesions Neurological research 21 1999 385 390
37. S. Goodall, M. Crowther, D.M. Hemingway, P.R. Bell, and M.M. Thompson Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms Circulation. 104 2001 304 309
38. S. Jung, K.S. Moon, T.Y. Jung, I.Y. Kim, Y.H. Lee, H.H. Rhu, and et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage J Neurooncol. 76 2006 257 263
39. L.B. Morgenstern, J.C. Hemphill 3rd, C. Anderson, K. Becker, J.P. Broderick, E.S. Connolly Jr., and et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke. 41 2010 2108 2129
40. J.B. Bederson, E.S. Connolly Jr., H.H. Batjer, R.G. Dacey, J.E. Dion, M.N. Diringer, and et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association Stroke. 40 2009 994 1025
41. A.D. Mendelow, B.A. Gregson, E.N. Rowan, R. Francis, E. McColl, P. McNamee, and et al. Early Surgery versus Initial Conservative Treatment in Patients with Traumatic Intracerebral Hemorrhage (STITCH[Trauma]): The First Randomized Trial Journal of neurotrauma. 32 2015 1312 1323
42. A. Holbrook, S. Schulman, D.M. Witt, P.O. Vandvik, J. Fish, M.J. Kovacs, and et al. Evidence-based management of anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines Chest. 141 2012 e152S e184S
43. S.A. Mayer, N.C. Brun, K. Begtrup, J. Broderick, S. Davis, M.N. Diringer, and et al. Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage New England Journal of Medicine. 358 2008 2127 2137
44. C.V. Pollack, P.A. Reilly, J. Eikelboom, S. Glund, P. Verhamme, R.A. Bernstein, and et al. Idarucizumab for Dabigatran Reversal New England Journal of Medicine. 373 2015 511 520
45. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. New England Journal of Medicine.0:null.
46. G.H. Lyman, K. Bohlke, A.A. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, and et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014 J Clin Oncol. 33 2015 654 656
47. R.L. Ruff, and J.B. Posner Incidence and treatment of peripheral venous thrombosis in patients with glioma Annals of neurology. 13 1983 334 336
48. E. Pan, J.S. Tsai, and S.B. Mitchell Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients Anticancer Res. 29 2009 4309 4313